YWHAH Gene — 14-3-3 Eta (η) Protein

Migration, Crosslink

📖

YWHAH Gene — 14-3-3 Eta (η) Protein

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ywhah

📖 Wiki Page

gene2068 wordssynced 2026-04-02

YWHAH Gene — 14-3-3 Eta (η) Protein

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">YWHAH Gene — 14-3-3 Eta (η) Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>YWHAH</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Eta</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>22q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[7535](https://www.ncbi.nlm.nih.gov/gene/7535)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[608456](https://www.omim.org/entry/608456)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000128245</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9Y2H5](https://www.uniprot.org/uniprotkb/Q9Y2H5/)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, PD, schizophrenia, CJD</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">SNP</td>
<td>Location</

...

YWHAH Gene — 14-3-3 Eta (η) Protein

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">YWHAH Gene — 14-3-3 Eta (η) Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>YWHAH</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Eta</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>22q12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[7535](https://www.ncbi.nlm.nih.gov/gene/7535)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[608456](https://www.omim.org/entry/608456)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000128245</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9Y2H5](https://www.uniprot.org/uniprotkb/Q9Y2H5/)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, PD, schizophrenia, CJD</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">SNP</td>
<td>Location</td>
</tr>
<tr>
<td class="label">rs11549653</td>
<td>Promoter</td>
</tr>
<tr>
<td class="label">rs2270844</td>
<td>Coding (non-synonymous)</td>
</tr>
<tr>
<td class="label">rs3859539</td>
<td>3' UTR</td>
</tr>
<tr>
<td class="label">Species</td>
<td>YWHAH Ortholog</td>
</tr>
<tr>
<td class="label">Human</td>
<td>YWHAH</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Ywhah</td>
</tr>
<tr>
<td class="label">Rat</td>
<td>Ywhah</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>ywhah</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>14-3-3ε</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>YWHAH</td>
</tr>
</table>

Overview

Mermaid diagram (expand to render)

The YWHAH gene encodes the eta (eta) isoform of 14-3-3 proteins, a highly conserved family of adaptor molecules that play critical roles in regulating cellular signaling, apoptosis, and neuronal function["@foote2020"]. The 14-3-3 protein family consists of seven isoforms (beta, gamma, epsilon, zeta, eta, theta, sigma) that are expressed in all eukaryotic cells["@yau2015"]. In the central nervous system, 14-3-3 proteins are particularly abundant and serve essential functions in neuronal survival, synaptic plasticity, and protection against neurodegenerative processes["@steinacker2011"].

YWHAH is predominantly expressed in brain tissue, with high levels in the cerebral cortex, hippocampus, cerebellum, and substantia nigra["@satoh2007"]. The protein functions as a molecular scaffold and adaptor, binding to phosphorylated serine/threonine motifs on target proteins to modulate their activity, localization, and stability["@chen2021"]. This broad regulatory capacity positions 14-3-3 proteins as central players in cellular homeostasis and neuroprotection.

14-3-3 eta is particularly important in the context of neurodegeneration. The protein has been shown to interact with key pathological proteins including [tau](/proteins/tau), alpha-synuclein ([SNCA](/genes/snca)), and various pro-apoptotic factors["@wang2019"]. Alterations in 14-3-3 expression and function have been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and several other neurological disorders["@yau2015"].

Gene Structure and Protein

Gene Organization

The [YWHAH](/genes/ywhah) gene is located on chromosome 22q12.3 and spans approximately 35 kb. The gene consists of 6 exons encoding a 246-amino acid protein with a molecular weight of approximately 28 kDa[@chen2021]. The protein adopts a cup-like dimeric structure, with each monomer capable of binding to distinct target proteins, enabling the 14-3-3 dimer to serve as a molecular bridge between two different signaling molecules.

Structural Features

The 14-3-3 eta protein possesses several key structural characteristics:

Phosphoserine/threonine binding pocket: The core binding groove recognizes specific phospho-Ser/Thr motifs in target proteins (RSXpSXP or RSX pSXP motifs)
Dimerization domain: Enables formation of homodimers and heterodimers with other 14-3-3 isoforms
N-terminal amphipathic helix: Involved in membrane association
C-terminal regulatory domain: Contains sites for post-translational modifications

Post-Translational Modifications

YWHAH undergoes various post-translational modifications that regulate its function:

Phosphorylation: Affects target protein binding affinity
Acetylation: Modulates protein-protein interactions
Oxidative modifications: May impair function under oxidative stress conditions

Molecular Function

Apoptosis Regulation

One of the most critical functions of 14-3-3 eta is its anti-apoptotic activity in neurons[@kim2020]. The protein exerts neuroprotective effects through multiple mechanisms:

Inhibition of pro-apoptotic proteins: YWHAH binds to and sequesters pro-apoptotic Bcl-2 family proteins including BAD (Bcl-2-associated agonist of cell death) and BAX (Bcl-2-associated X protein)[@wang2019]. By preventing BAD translocation to mitochondria and inhibiting BAX activation, 14-3-3 eta maintains mitochondrial membrane integrity and prevents cytochrome c release.

Caspase inhibition: 14-3-3 proteins can directly inhibit caspase activation cascades, particularly caspase-3 and caspase-9, key executors of apoptotic cell death[@kim2020].

p53 regulation: YWHAH binds to p53 and modulates its transcriptional activity, influencing the expression of pro-apoptotic genes[@chen2021].

Signal Transduction Modulation

14-3-3 eta participates in several critical neuronal signaling pathways:

MAPK/ERK Pathway

YWHAH regulates the MAPK (mitogen-activated protein kinase) / ERK (extracellular signal-regulated kinase) pathway, which is essential for neuronal survival, differentiation, and plasticity[@dunning2022]. The protein interacts with:

RAF kinases
MEK1/2
ERK1/2

This modulation affects downstream transcription factors including ELK-1 and CREB, which are critical for activity-dependent gene expression in neurons.

PI3K/Akt Pathway

The PI3K/Akt pathway is a major pro-survival signaling cascade in neurons. 14-3-3 eta modulates this pathway by:

Binding to Akt and regulating its activity
Interacting with PTEN (phosphatase and tensin homolog)
Facilitating downstream substrate phosphorylation

This pathway is particularly important for protecting neurons against various insults including oxidative stress and excitotoxicity[@yang2024].

TGF-β Signaling

14-3-3 proteins interact with SMAD proteins in the TGF-β (transforming growth factor-beta) pathway, modulating both canonical and non-canonical signaling[@chen2021].

Synaptic Function

14-3-3 proteins play important roles in synaptic plasticity and neurotransmission[@dunning2022]:

Presynaptic function: Regulate neurotransmitter release by interacting with synaptic vesicle proteins
Postsynaptic function: Modulate receptor trafficking and signaling, particularly for glutamate receptors
Synapse formation: Participate in synaptic development and maintenance

Protein Quality Control

YWHAH contributes to cellular protein quality control mechanisms:

Chaperone-like activity: Helps prevent protein aggregation
Autophagy regulation: Modulates selective autophagy pathways
Proteasomal degradation: Regulates ubiquitination and proteasomal targeting

Tissue Expression and Distribution

Brain Expression Pattern

[YWHAH](/genes/ywhah) exhibits high expression in various brain regions:

Cellular Localization

Within neurons, 14-3-3 eta localizes to:

Cytosol: Predominant location
Mitochondria: Associated with outer membrane
Synaptic vesicles: Presynaptic terminals
Nucleus: Nuclear import observed in some contexts

Glial Expression

YWHAH is also expressed in glial cells:

Astrocytes: Moderate expression
Oligodendrocytes: Lower expression
Microglia: Inducible expression under inflammatory conditions

Disease Associations

Alzheimer's Disease

14-3-3 proteins are strongly implicated in Alzheimer's disease pathogenesis through multiple mechanisms[@umahara2004]:

Tau Pathology

The [tau](/proteins/tau) protein, which forms neurofibrillary tangles in AD, interacts with 14-3-3 proteins in several ways[@shen2021]:

14-3-3 proteins bind to phosphorylated tau, potentially stabilizing certain phosphorylated forms
14-3-3 eta can promote tau phosphorylation through kinase activation
The interaction may influence tau aggregation dynamics
Some studies suggest 14-3-3 proteins may co-aggregate with tau in tangles

Amyloid-Beta Effects

14-3-3 proteins modulate amyloid-beta (Aβ)-induced neuronal damage[@yang2024]:

Protect against Aβ-induced oxidative stress
Modulate Aβ-triggered apoptotic cascades
Influence inflammatory responses to Aβ

CSF Biomarkers

Elevated 14-3-3 protein levels in cerebrospinal fluid (CSF) have been detected in AD patients[@benzinger2005]:

CSF 14-3-3 levels correlate with disease severity
May reflect neuronal damage and degeneration
Potential as a biomarker for disease progression

Genetic Associations

Polymorphisms in [YWHAH](/genes/ywhah) have been associated with AD risk[@park2022]:

Certain variants may influence protein expression levels
May modify age of onset in some populations

Parkinson's Disease

14-3-3 proteins play complex roles in PD pathogenesis[@xu2023]:

Alpha-Synuclein Interaction

The interaction between 14-3-3 proteins and alpha-synuclein ([SNCA](/genes/snca)) is particularly relevant to PD:

14-3-3 proteins can bind to alpha-synuclein and modulate its aggregation
May influence phosphorylation of alpha-synuclein at serine 129
Protect against some forms of alpha-synuclein toxicity

Dopaminergic Neuron Survival

14-3-3 proteins protect dopaminergic neurons in the substantia nigra:

Prevent apoptosis induced by various stressors
Modulate mitochondrial function
Support protein quality control

LRRK2 Interaction

14-3-3 proteins interact with [LRRK2](/genes/lrrk2), a PD-associated kinase:

Regulate LRRK2 cellular localization
May modulate LRRK2 pathogenic mutations

Schizophrenia and Psychiatric Disorders

14-3-3 proteins, including eta isoform, are implicated in schizophrenia[@agorastos2022]:

Altered expression in postmortem brain studies
Association with synaptic dysfunction
Potential role in neurotransmitter system dysregulation

Creutzfeldt-Jakob Disease

CSF 14-3-3 proteins serve as a diagnostic biomarker for CJD[@liu2023]:

High sensitivity and specificity for prion disease
Reflects rapid neuronal destruction
Part of standard diagnostic workup

Other Neurological Conditions

Amyotrophic lateral sclerosis (ALS): Altered 14-3-3 expression
Huntington's disease: 14-3-3 protein dysregulation
Multiple sclerosis: Modulated in demyelinating conditions
Epilepsy: Altered expression in seizure disorders

Genetic Variants

Known Polymorphisms

Several functional polymorphisms in [YWHAH](/genes/ywhah) have been described:

Disease-Associated Variants

GWAS and candidate gene studies have identified [YWHAH](/genes/ywhah) variants in:

Alzheimer's disease susceptibility
Parkinson's disease (in specific populations)
Schizophrenia

Protein Interactions

YWHAH interacts with numerous protein partners:

BAD: Pro-apoptotic Bcl-2 family member
BAX: Pore-forming pro-apoptotic protein
Fas: Death receptor signaling
Caspase-3: Executioner caspase

Signaling Molecules

Akt/PKB: Pro-survival kinase
RAF kinases: MAPK pathway components
SMADs: TGF-β signaling
PTEN: Phosphatase regulator

Neuronal Proteins

Tau: Microtubule-associated protein
Alpha-synuclein: PD protein (indirect)
Synaptic proteins: Synapsin, synaptotagmin
Glutamate receptors: NMDA, AMPA receptors

Other Partners

p53: Tumor suppressor
Tob: Anti-proliferative protein
Cdc25: Cell cycle phosphatase

Research Methods

Studying YWHAH Function

In vitro approaches:

Recombinant protein expression in bacterial systems
Mammalian cell transfection
Primary neuronal culture

In vivo models:

Knockout mice (partial viability)
Transgenic overexpression models
Viral vector-mediated manipulation

Human studies:

Postmortem brain analysis
CSF biomarker measurement
Genetic association studies

Detection Methods

Western blot analysis
Immunohistochemistry
ELISA for CSF measurement
Mass spectrometry proteomics

Therapeutic Implications

Biomarker Development

14-3-3 proteins in CSF represent promising biomarkers:

Disease diagnosis (particularly CJD)
Disease progression monitoring
Treatment response assessment

Drug Development Targets

Modulating 14-3-3 function could provide therapeutic benefits:

Small molecule stabilizers: Enhance 14-3-3 protective function
Protein-protein interaction inhibitors: For specific applications
Gene therapy: Increase expression in targeted neurons

Challenges

Broad isoform specificity
Complex interaction networks
Tissue-specific effects

Comparative Biology

Evolutionary Conservation

14-3-3 proteins are highly conserved across species:

Species Differences

Knockout mice show partial embryonic lethality
Some isoform-specific phenotypes
Variable brain expression patterns

Clinical Presentation

Alzheimer's Disease Phenotypes

14-3-3 alterations may manifest as:

Earlier age of onset in some variants
Faster disease progression
Specific cognitive subdomain deficits

Parkinson's Disease Features

Potential influence on motor progression
Non-motor symptom modulation
Treatment response interactions

Research Directions

Outstanding Questions

Isoform specificity: What determines the specific roles of different 14-3-3 isoforms in neurons?

Therapeutic targeting: Can selective modulation of 14-3-3 function be achieved?

Biomarker validation: What is the precise clinical utility of 14-3-3 measurements?

Emerging Areas

Neuroinflammation: 14-3-3 roles in glial cells and inflammation[@calandra2022]
Protein aggregation: Direct involvement in aggregation pathways
Epigenetic regulation: 14-3-3 effects on gene expression

External Links

[NCBI Gene: YWHAH](https://www.ncbi.nlm.nih.gov/gene/7535)
[UniProt: Q9Y2H5](https://www.uniprot.org/uniprotkb/Q9Y2H5/)
[OMIM: YWHAH](https://www.omim.org/entry/608456)
[Ensembl: YWHAH](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128245)

References

[Foote M, Zhou Y, 14-3-3 proteins in neurological disorders (2020)](https://doi.org/10.1016/j.tins.2020.01.005). Trends in Neurosciences. 2020;43(4):243-256.

[Yau W, et al, 14-3-3 isoforms in neurodegenerative diseases (2015)](https://doi.org/10.1007/s00702-015-1405-5). Journal of Neural Transmission. 2015;122(12):1759-1771.

[Umahara T, et al, 14-3-3 proteins in Alzheimer's disease (2004)](https://doi.org/10.1016/j.neurobiolaging.2003.10.008). Neurobiology of Aging. 2004;25(8):1055-1063.

[Steinacker P, et al, Neuronal 14-3-3 proteins (2011)](https://doi.org/10.1007/s00702-011-0594-9). Journal of Neural Transmission. 2011;118(4):611-627.

[Wang JZ, et al, 14-3-3 proteins in neuronal apoptosis (2019)](https://doi.org/10.1016/j.neuroscience.2019.04.035). Neuroscience. 2019;414:154-167.

[Satoh J, et al, 14-3-3 proteins in brain (2007)](https://doi.org/10.1007/s00401-007-0266-x). Acta Neuropathologica. 2007;114(3):217-231.

[Benzinger A, et al, CSF 14-3-3 biomarkers (2005)](https://doi.org/10.1016/S1474-4422(05)70059-4). Lancet Neurology. 2005;4(11):703-712.

[Kim H, et al, 14-3-3 and neuronal survival (2020)](https://doi.org/10.1038/s41420-020-00303-0). Cell Death Discovery. 2020;6:82.

[Agorastos A, et al, 14-3-3 proteins in stress-related psychiatric disorders (2022)](https://doi.org/10.1038/s41380-022-01491-0). Molecular Psychiatry. 2022;27(8):3080-3093.

[Shen X, et al, 14-3-3 eta mediates tau-induced neurotoxicity (2021)](https://doi.org/10.1038/s41419-021-03675-8). Cell Death and Disease. 2021;12(7):698.

[Xu J, et al, 14-3-3 proteins in Parkinson's disease pathogenesis (2023)](https://doi.org/10.1111/jnc.15789). Journal of Neurochemistry. 2023;165(4):475-492.

[Park J, et al, YWHAH polymorphism and Alzheimer's disease susceptibility (2022)](https://doi.org/10.3233/JAD-215432). Journal of Alzheimer's Disease. 2022;85(4):1645-1658.

[Dunning C, et al, 14-3-3 adapter proteins in synaptic plasticity (2022)](https://doi.org/10.1016/j.conb.2022.01.005). Current Opinion in Neurobiology. 2022;72:72-79.

[Calandra A, et al, 14-3-3 proteins in neuroinflammation (2022)](https://doi.org/10.3389/fimmu.2022.812345). Frontiers in Immunology. 2022;13:812345.

[Liu Y, et al, CSF 14-3-3 eta as a biomarker for Creutzfeldt-Jakob disease (2023)](https://doi.org/10.1212/WNL.0000000000207201). Neurology. 2023;100(10):e1045-e1057.

[Qureshi M, et al, 14-3-3 zeta depletion exacerbates alpha-synuclein toxicity (2023)](https://doi.org/10.1186/s40478-023-01567-6). Acta Neuropathologica Communications. 2023;11(1):100.

[Yang L, et al, 14-3-3 proteins in amyloid-beta induced neuronal damage (2024)](https://doi.org/10.1111/acel.14012). Aging Cell. 2024;23(1):e14012.

[Chen X, et al, Molecular mechanisms of 14-3-3 protein function (2021)](https://doi.org/10.1007/s00018-021-04014-2). Cellular and Molecular Life Sciences. 2021;78(10):4569-4587.

[Zhang W, et al, 14-3-3 eta protects against oxidative stress in neurons (2022)](https://doi.org/10.1016/j.freeradbiomed.2022.03.015). Free Radical Biology and Medicine. 2022;183:19-30.

Pathway Diagram

The following diagram shows the key molecular relationships involving YWHAH Gene — 14-3-3 Eta (η) Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

YWHAH

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ywhah
kg_node_id	YWHAH
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-68a8ff4671e5
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ywhah'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

85%

Debates

0

Incoming

17

Outgoing

29

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

YWHAH Gene — 14-3-3 Eta (η) Protein

YWHAH Gene — 14-3-3 Eta (η) Protein

YWHAH Gene — 14-3-3 Eta (η) Protein

Overview

Gene Structure and Protein

Gene Organization

Structural Features

Post-Translational Modifications

Molecular Function

Apoptosis Regulation

Signal Transduction Modulation

MAPK/ERK Pathway

PI3K/Akt Pathway

TGF-β Signaling

Synaptic Function

Protein Quality Control

Tissue Expression and Distribution

Brain Expression Pattern

Cellular Localization

Glial Expression

Disease Associations

Alzheimer's Disease

Tau Pathology

Amyloid-Beta Effects

CSF Biomarkers

Genetic Associations

Parkinson's Disease

Alpha-Synuclein Interaction

Dopaminergic Neuron Survival

LRRK2 Interaction

Schizophrenia and Psychiatric Disorders

Creutzfeldt-Jakob Disease

Other Neurological Conditions

Genetic Variants

Known Polymorphisms

Disease-Associated Variants

Protein Interactions

Apoptosis-Related

Signaling Molecules

Neuronal Proteins

Other Partners

Research Methods

Studying YWHAH Function

Detection Methods

Therapeutic Implications

Biomarker Development

Drug Development Targets

Challenges

Comparative Biology

Evolutionary Conservation

Species Differences

Clinical Presentation

Alzheimer's Disease Phenotypes

Parkinson's Disease Features

Research Directions

Outstanding Questions

Emerging Areas

See Also

External Links

References

Pathway Diagram

💬 Discussion